W Ray Kim

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma
    W Ray Kim
    Mayo Clinic College of Medicine, Division of Gastroenterology, Rochester, MN 55905, USA
    Clin Liver Dis 9:225-34. 2005
  2. ncbi request reprint Outcome of liver transplantation for hepatitis B in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Liver Transpl 10:968-74. 2004
  3. ncbi request reprint Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements
    Kiran Bambha
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA
    Am J Transplant 4:1798-804. 2004
  4. ncbi request reprint MELD accurately predicts mortality in patients with alcoholic hepatitis
    Winston Dunn
    Advanced Liver Disease Study Group, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 41:353-8. 2005
  5. ncbi request reprint Mortality and hospital utilization for hepatocellular carcinoma in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 129:486-93. 2005
  6. doi request reprint Hyponatremia and mortality among patients on the liver-transplant waiting list
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    N Engl J Med 359:1018-26. 2008
  7. doi request reprint Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
    W Ray Kim
    Mayo Clinic College of Medicine, Rochester, MN, USA
    Hepatology 47:1363-70. 2008
  8. pmc Epidemiology of hepatitis B in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 49:S28-34. 2009
  9. pmc Trends in waiting list registration for liver transplantation for viral hepatitis in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 137:1680-6. 2009
  10. doi request reprint Impact of MELD on waitlist outcome of retransplant candidates
    H J Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Am J Transplant 10:2652-7. 2010

Detail Information

Publications76

  1. ncbi request reprint The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma
    W Ray Kim
    Mayo Clinic College of Medicine, Division of Gastroenterology, Rochester, MN 55905, USA
    Clin Liver Dis 9:225-34. 2005
    ....
  2. ncbi request reprint Outcome of liver transplantation for hepatitis B in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Liver Transpl 10:968-74. 2004
    ..In conclusion, these data underscore the effectiveness of therapeutic innovations that have occurred in the past two decades and indicate timely and widespread adoption of these measures by transplant centers nationwide...
  3. ncbi request reprint Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements
    Kiran Bambha
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA
    Am J Transplant 4:1798-804. 2004
    ..Delta MELD is predictive of death only within 4 d of the event; however, part of this correlates with the dying process itself, thus limiting Delta MELD's utility in survival prediction models...
  4. ncbi request reprint MELD accurately predicts mortality in patients with alcoholic hepatitis
    Winston Dunn
    Advanced Liver Disease Study Group, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 41:353-8. 2005
    ..MELD is a useful clinical tool for gauging mortality and guiding treatment decisions in patients with AH, particularly those complicated by ascites and/or encephalopathy...
  5. ncbi request reprint Mortality and hospital utilization for hepatocellular carcinoma in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 129:486-93. 2005
    ..Hospital service utilization was estimated based on length of stay, total hospitalization charges, and principal procedures...
  6. doi request reprint Hyponatremia and mortality among patients on the liver-transplant waiting list
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    N Engl J Med 359:1018-26. 2008
    ..Under the current liver-transplantation policy, donor organs are offered to patients with the highest risk of death...
  7. doi request reprint Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
    W Ray Kim
    Mayo Clinic College of Medicine, Rochester, MN, USA
    Hepatology 47:1363-70. 2008
  8. pmc Epidemiology of hepatitis B in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 49:S28-34. 2009
    ....
  9. pmc Trends in waiting list registration for liver transplantation for viral hepatitis in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 137:1680-6. 2009
    ....
  10. doi request reprint Impact of MELD on waitlist outcome of retransplant candidates
    H J Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Am J Transplant 10:2652-7. 2010
    ..We conclude that by and large, primary and ReTx candidates fare equitably under the current MELD-based allocation system, which has contributed to a significant increase in the probability of LTx...
  11. doi request reprint A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation
    Michael D Leise
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55906, USA
    Gastroenterology 140:1952-60. 2011
    ..An updated MELD based on data from patients awaiting liver transplantation should improve mortality prediction and allocation efficiency...
  12. pmc Biliary tract cancers in Olmsted County, Minnesota, 1976-2008
    Ju Dong Yang
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Gastroenterol 107:1256-62. 2012
    ..The aim of this study is to evaluate biliary tract cancers with regard to the incidence rates, etiology, treatment, and survival in Olmsted County between 1976 and 2008...
  13. pmc Model to estimate survival in ambulatory patients with hepatocellular carcinoma
    Ju Dong Yang
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 56:614-21. 2012
    ..The concordance (c)-statistic for this model (0.77) was superior to that for BCLC (0.71), CLIP (0.70), or JIS (0.70). The score was able to further classify patient survival within each stage of the BCLC classification...
  14. ncbi request reprint Deaths on the liver transplant waiting list: an analysis of competing risks
    W Ray Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 43:345-51. 2006
    ..In conclusion, the competing risk analysis method is useful in estimating the risk of death among patients awaiting liver transplantation...
  15. pmc Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008
    Ju Dong Yang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:9-16. 2012
    ..To analyze longitudinal trends in the incidence, etiology, and treatment of hepatocellular carcinoma (HCC) in community residents in Olmsted County, Minnesota, and their survival...
  16. pmc Impact of pretransplant hyponatremia on outcome following liver transplantation
    Byung Cheol Yun
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 49:1610-5. 2009
    ..The incidence of CPM correlates with hyponatremia, although its overall incidence is low. Incorporation of serum sodium in organ allocation may not adversely affect the overall post-OLT outcome...
  17. doi request reprint Serum sodium, renal function, and survival of patients with end-stage liver disease
    Young Suk Lim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Hepatol 52:523-8. 2010
    ..We investigate the role of serum creatinine and sodium, and glomerular filtration rate (GFR) as determinants of survival in patients with ESLD...
  18. doi request reprint Impact of the center on graft failure after liver transplantation
    Sumeet K Asrani
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MI Annette C and Harold C Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
    Liver Transpl 19:957-64. 2013
    ..30-fold interquartile difference). In conclusion, the LT center is a significant predictor of graft failure that is independent of region and DSA as well as donor and recipient characteristics...
  19. pmc Model for end-stage liver disease: end of the first decade
    Sumeet K Asrani
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Liver Dis 15:685-98. 2011
    ..The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future...
  20. doi request reprint Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation
    Sarwa Darwish Murad
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Liver Transpl 19:521-8. 2013
    ..These results are important in light of the continued debate about the feasibility of this aggressive treatment in patients with perihilar CCA...
  21. pmc Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk
    Roongruedee Chaiteerakij
    Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Hepatology 57:648-55. 2013
    ..4; 95% CI: 0.2-0.9; P = 0.04). Obesity and metabolic syndrome were not associated with ICC...
  22. ncbi request reprint Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysis
    Jayant A Talwalkar
    Transplant Center, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:431-5. 2003
    ..To determine the level of association between minimal listing criteria (MLC) recognition and outcomes associated with waiting list registration for liver transplantation (LT)...
  23. ncbi request reprint Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation
    Michael D Leise
    William J von Leibig Transplant Center, Mayo Clinic, Rochester, MN, Mayo Clinic, Rochester, MN
    Liver Transpl 20:687-97. 2014
    ..001). In conclusion, hyponatremia per se does not affect post-LT survival. Pre-LT hypernatremia is a highly significant risk factor for post-LT mortality...
  24. pmc Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant
    Kiran Bambha
    Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, Denver, USA
    Mayo Clin Proc 85:814-20. 2010
    ..To identify single nucleotide polymorphisms (SNPs) associated with risk of developing chronic kidney disease (CKD), a prevalent comorbidity, after liver transplant (LT)...
  25. ncbi request reprint Natural history of hepatitis B virus infection: an update for clinicians
    Surakit Pungpapong
    Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:967-75. 2007
    ....
  26. ncbi request reprint Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community
    Kiran Bambha
    Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Gastroenterology 125:1364-9. 2003
    ..The epidemiology of primary sclerosing cholangitis (PSC) in the United States is unknown. We report the incidence, clinical spectrum, and outcomes of PSC in Olmsted County, Minnesota...
  27. ncbi request reprint MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients
    Walter K Kremers
    The William J von Liebig Transplant Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    Hepatology 39:764-9. 2004
    ..68). In conclusion, liver allocation within the Status 1 designation may need to be further stratified by diagnosis, and MELD score may be useful for prioritizing FHF-NA candidates...
  28. ncbi request reprint Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C
    Badr Al-Bawardy
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
    Mayo Clin Proc 89:595-601. 2014
    ....
  29. pmc Underestimation of liver-related mortality in the United States
    Sumeet K Asrani
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 145:375-82.e1-2. 2013
    ..However, this single descriptor might not adequately enumerate all deaths from liver disease. The aim of our study was to update data on liver mortality in the United States...
  30. pmc Donor race does not predict graft failure after liver transplantation
    Sumeet K Asrani
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 138:2341-7. 2010
    ..We evaluated the extent to which the center where the transplantation surgery was performed and other potential confounding factors might account for the observed association between donor race and graft failure...
  31. ncbi request reprint Changing epidemiology of hepatitis B in a U.S. community
    W Ray Kim
    Division of Gastroenterology and Hepatology Mayo 16E, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Hepatology 39:811-6. 2004
    ..69) and age greater than 40 years (OR = 2.32 per decade). In conclusion, in this Midwestern community, chronic HBV infection was predominantly seen in immigrants from endemic parts of the world...
  32. doi request reprint Serum aminotransferase activity and mortality risk in a United States community
    Tae Hoon Lee
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Hepatology 47:880-7. 2008
    ..78 for >2x ULN). SMR was also higher for abnormal ALT (SMR = 1.21 for 1-2x ULN and 1.51 for >2x ULN). In contrast, normal AST or ALT was associated with a risk of death lower than expected (SMR 0.95 for AST, 0.61 for ALT)...
  33. doi request reprint Factors that affect risk for hepatocellular carcinoma and effects of surveillance
    Ju Dong Yang
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 9:617-23.e1. 2011
    ..We evaluated risk factors for HCC, the proportion of cases detected via surveillance, tumor characteristics, treatment approaches, and overall patient survival in a referral center cohort...
  34. pmc Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography
    Donghee Kim
    Division of Gastroenterology and Hepatology and Department of Diagnostic Radiology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Radiology 268:411-9. 2013
    ....
  35. pmc Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
    Donghee Kim
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Hepatology 57:1357-65. 2013
    ..However, advanced fibrosis, as determined by noninvasive fibrosis marker panels, is a significant predictor of mortality, mainly from cardiovascular causes, independent of other known factors...
  36. pmc Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat
    Liliana Gazzuola Rocca
    Department of Clinical Research, Olmsted Medical Center, Rochester, Minn 55904, USA
    Ann Fam Med 2:116-24. 2004
    ..The rate of hepatitis C treatment is low, however. This study explores the frequency of hepatitis C treatment, documented discussions of treatment consideration, and the reasons treatment may not be offered in a community population...
  37. ncbi request reprint The model for end-stage liver disease (MELD)
    Patrick S Kamath
    Advanced Liver Disease Study Group, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 45:797-805. 2007
    ..It is possible that the addition of variables that are better determinants of liver and renal function may improve the predictive accuracy of the model. Efforts at further refinement and validation of the MELD score will continue...
  38. pmc Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma
    Sarwa Darwish Murad
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 56:972-81. 2012
    ..8; P = 0.01), portal vein encasement (HR 3.3; P = 0.007), and residual tumor on explant (HR 9.8; P < 0.001). Primary sclerosing cholangitis (PSC), age, history of cholecystectomy, and waiting time were not independent predictors...
  39. doi request reprint Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis
    Corlan O Adebajo
    Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Liver Transpl 18:323-31. 2012
    ..The detection of significant fibrosis is more accurate for these patients versus patients whose native liver is chronically infected with HCV...
  40. doi request reprint The global impact of hepatic fibrosis and end-stage liver disease
    Young Suk Lim
    Division of Gastroenterology and Hepatology PL 6, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Liver Dis 12:733-46, vii. 2008
    ..Moreover, the burden of chronic liver disease is projected to increase, due in part to the increasing prevalence of end-stage liver disease and HCC secondary to NAFLD and HCV...
  41. doi request reprint Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis
    Sumeet K Asrani
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Hepatology 52:1360-70. 2010
    ..47, 95% CI = 1.14-5.36), rash (RR = 7.57, 95% CI = 1.75-32.70), ulcers (RR = 7.44, 95% CI = 2.03-27.28), and discontinuation of therapy (RR = 3.61, 95% CI = 1.32-9.89)...
  42. ncbi request reprint The impact of competing risks on the observed rate of chronic hepatitis C progression
    W Ray Kim
    Mayo Clinic and Foundation Ch10, 200 First Street Southwest, Rochester, Minnesota 55905, USA
    Gastroenterology 127:749-55. 2004
    ..A simulation experiment was conducted to measure the magnitude of the effect of competing risks on the observed rate of fibrosis progression of CHC...
  43. ncbi request reprint Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease
    Charmaine A Stewart
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Liver Transpl 13:1366-71. 2007
    ..HE may provide additional prognostic information independent of MELD, which warrants prospective validation...
  44. ncbi request reprint Risk factors for mortality after surgery in patients with cirrhosis
    Swee H Teh
    Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, Minnesota, USA
    Gastroenterology 132:1261-9. 2007
    ..The aim of this study was to determine the risk factors for postoperative mortality in patients with cirrhosis...
  45. ncbi request reprint Employment and health insurance in long-term liver transplant recipients
    Catherine Rongey
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Transplant 5:1901-8. 2005
    ..1), physical function score>52.4 (OR=3.6) and general health score>33.3 (OR=7.6) were significantly associated with employment. These data may help identify high-risk pre-OLT patients for intervention measures such as work rehabilitation...
  46. pmc Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease
    Alina M Allen
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Clin Gastroenterol Hepatol 11:1655-60.e1. 2013
    ..We investigated the risk of exacerbation of IBD during HCV therapy and the rate of adverse effects of concomitant therapy for HCV and IBD. We also evaluated the efficacy of HCV treatment in the IBD population...
  47. ncbi request reprint Management of hepatic encephalopathy in the hospital
    Michael D Leise
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN Electronic address
    Mayo Clin Proc 89:241-53. 2014
    ..Last, patients and their families should be counseled about the risk of motor vehicle accidents, which require mandatory reporting to the Department of Motor Vehicles in some states...
  48. ncbi request reprint Survival after liver transplantation: Is racial disparity inevitable?
    Tae Hoon Lee
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN, USA
    Hepatology 46:1491-7. 2007
    ..CONCLUSION: These data demonstrate that as a proof of principle, minority OLT recipients should not necessarily expect an OLT outcome inferior to that of Caucasians...
  49. ncbi request reprint Burden of liver disease in the United States: summary of a workshop
    W Ray Kim
    Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Hepatology 36:227-42. 2002
  50. doi request reprint Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C
    Stanley S Liu
    Viral Hepatitis Study Group, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA
    J Clin Gastroenterol 44:e178-85. 2010
    ..The aim of our study was to examine the influence of antidepressant treatment and whether this improves the likelihood of completing therapy...
  51. pmc The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure
    Patrick S Kamath
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Clin Liver Dis 13:63-6. 2009
    ..8, indicating excellent discrimination...
  52. doi request reprint Hospitalization for underage drinkers in the United States
    Jason Y Kim
    Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    J Adolesc Health 50:648-50. 2012
    ..Underage drinking is common in the United States. This article presents nationally representative data on hospitalizations for alcohol use disorder (AUD) in youth...
  53. ncbi request reprint Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
    Kiran Bambha
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Eur J Gastroenterol Hepatol 16:519-26. 2004
    ....
  54. pmc Alcoholic liver disease-related mortality in the United States: 1980-2003
    Helga Paula
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 105:1782-7. 2010
    ....
  55. pmc Organ allocation for chronic liver disease: model for end-stage liver disease and beyond
    Sumeet K Asrani
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Curr Opin Gastroenterol 26:209-13. 2010
    ..Prognostic models have been proposed to either refine or improve the current MELD-based liver allocation...
  56. ncbi request reprint Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites
    Luke T Evans
    Advanced Liver Diseases Study Group, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 37:897-901. 2003
    ..In addition, the organisms cultured from ascitic fluid in outpatients are predominantly gram positive. A reassessment of diagnostic criteria for spontaneous bacterial peritonitis in outpatients may be required...
  57. ncbi request reprint The burden of hepatitis C in the United States
    W Ray Kim
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
    Hepatology 36:S30-4. 2002
    ..e., those with infection for 20 years or longer), suggesting a continued rise in the burden of HCV in the United States in the foreseeable future...
  58. pmc Increased prevalence and mortality in undiagnosed celiac disease
    Alberto Rubio-Tapia
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 137:88-93. 2009
    ..The historical prevalence and long-term outcome of undiagnosed celiac disease (CD) are unknown. We investigated the long-term outcome of undiagnosed CD and whether the prevalence of undiagnosed CD has changed during the past 50 years...
  59. pmc Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma
    Ju Dong Yang
    Mayo Clinic College of Medicine, Rochester, MN, USA
    Clin Gastroenterol Hepatol 9:64-70. 2011
    ..We compared patients with HCC and hepatitis B virus (HBV) or hepatitis C virus (HCV) infections to determine the proportions of cirrhosis in each group, virologic and tumor characteristics, and overall survival...
  60. pmc Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies
    Ju Dong Yang
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Gut Liver 4:537-42. 2010
    ..Serum YKL-40 has been linked to several human cancers. We investigated the potential role of serum YKL-40 as a marker of hepatobiliary malignancies...
  61. ncbi request reprint Motion - the available treatments for hepatitis C are cost effective: arguments against the motion
    W Ray Kim
    Department of Medicine, Mayo Clinic and Foundation, Rochester 55905, USA
    Can J Gastroenterol 16:710-5. 2002
    ..Given these limitations, vis- -vis the expense, toxicity and yet limited effectiveness of the currently available antiviral agents, one should not blindly accept a conclusion that treatment for hepatitis C is cost effective...
  62. ncbi request reprint Diagnosis and 10-year follow-up of a community-based hepatitis C cohort
    Barbara P Yawn
    Department of Clinical Research, Olmsted Medical Center, 210 Ninth St, SE, Rochester, MN 55904, USA
    J Fam Pract 51:135-40. 2002
    ..To determine the health care follow-up and treatment associated with physician-diagnosed hepatitis C (HCV) in a community-based population...
  63. ncbi request reprint Medical and economic impact of autoimmune hepatitis
    Jayant A Talwalkar
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, S W Rochester, MN 55905, USA
    Clin Liver Dis 6:649-67. 2002
    ..As a result, the ability to plan for disease management strategies in AIH that require the allocation of scarce resources will be feasible...
  64. ncbi request reprint Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation
    David J Vanness
    Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Health Econ 11:551-66. 2002
    ..The approach allows flexibility in assessing treatment in various counterfactual premises and quantifies the global effect of parametric uncertainty on a decision-maker's confidence in adopting one therapy over the other...
  65. pmc Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers
    Sarwa Darwish Murad
    William J von Liebig Transplant Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 143:88-98.e3; quiz e14. 2012
    ..We analyzed data from multiple centers to determine the effectiveness of this treatment and the appropriateness of the MELD exception...
  66. ncbi request reprint Development and maintenance of a community-based hepatitis C registry
    Barbara P Yawn
    Department of Clinical Research, Olmsted Medical Center, Rochester, MN 55904, USA
    Am J Manag Care 8:253-61. 2002
    ..To develop a model for community-population- or health system-based registries of all patients with diagnosed hepatitis C, to facilitate clinical care and epidemiologic studies...
  67. ncbi request reprint Is the change in MELD score a better indicator of mortality than baseline MELD score?
    Patrick S Kamath
    Liver Transpl 9:19-21. 2003
  68. ncbi request reprint Liver transplantation is effective, but is it cost-effective?
    Kiran Bambha
    Liver Transpl 9:1308-11. 2003
  69. ncbi request reprint Evidence-based incorporation of serum sodium concentration into MELD
    Scott W Biggins
    University of California San Francisco, San Francisco, California, USA
    Gastroenterology 130:1652-60. 2006
    ..Serum sodium (Na) concentrations have been suggested as a useful predictor of mortality in patients with end-stage liver disease awaiting liver transplantation...
  70. ncbi request reprint Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective?
    W Ray Kim
    Gastroenterology 134:641; author reply 641-2. 2008
  71. doi request reprint Benefits of "the benefit model" in liver transplantation
    W Ray Kim
    Hepatology 48:697-8. 2008
  72. ncbi request reprint Pretransplantation disease severity and posttransplantation outcome
    W Ray Kim
    Liver Transpl 9:124-5. 2003
  73. doi request reprint Mortality attributable to cholestatic liver disease in the United States
    Flavia D Mendes
    Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, FL, USA
    Hepatology 47:1241-7. 2008
    ..These changes may be attributable to liver transplantation or ursodeoxycholic acid. In contrast, mortality from PSC remained largely unchanged, highlighting the need for more effective therapeutic strategies...
  74. ncbi request reprint A glossary of economic terms
    Naoki Chiba
    Eur J Gastroenterol Hepatol 16:563-5. 2004
  75. ncbi request reprint Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
    Sarwa Darwish Murad
    Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Liver Transpl 13:867-74. 2007
    ..65-0.85). In conclusion, MELD showed a suboptimal discriminative ability to predict survival in BCS. This was explained by the highly variable degree of liver dysfunction and hence clinical outcome in BCS in contrast to ESLD...